Targeted reconstruction of T cell receptor sequence from single cell RNA-seq links CDR3 length to T cell differentiation state by Afik, Shaked et al.
Targeted reconstruction of T cell receptor
sequence from single cell RNA-seq links
CDR3 length to T cell differentiation state
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Afik, S., K. B. Yates, K. Bi, S. Darko, J. Godec, U. Gerdemann, L.
Swadling, et al. 2017. “Targeted reconstruction of T cell receptor
sequence from single cell RNA-seq links CDR3 length to T cell
differentiation state.” Nucleic Acids Research 45 (16): e148.
doi:10.1093/nar/gkx615. http://dx.doi.org/10.1093/nar/gkx615.
Published Version doi:10.1093/nar/gkx615
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:34868947
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
Published online 17 July 2017 Nucleic Acids Research, 2017, Vol. 45, No. 16 e148
doi: 10.1093/nar/gkx615
Targeted reconstruction of T cell receptor sequence
from single cell RNA-seq links CDR3 length to T cell
differentiation state
Shaked Afik1,†, Kathleen B. Yates2,†, Kevin Bi2,†, Samuel Darko3, Jernej Godec2,4,5,
Ulrike Gerdemann2, Leo Swadling6, Daniel C. Douek3, Paul Klenerman6,7, Eleanor
J. Barnes6,7, Arlene H. Sharpe4,5, W. Nicholas Haining2,8,9,* and Nir Yosef10,11,12,*
1Center for Computational Biology, University of California, Berkeley, Berkeley, CA, USA, 2Department of Pediatric
Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA, 3Human Immunology Section,
Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA, 4Department of Microbiology and Immunobiology,
Harvard Medical School, Boston, MA, USA, 5Evergrande Center for Immunologic Diseases, Harvard Medical School
and Brigham and Women’s Hospital, Boston, MA, USA, 6Translational Gastroenterology Unit, Peter Medawar
Building for Pathogen Research, University of Oxford, Oxford, UK, 7NIHR Oxford Biomedical Research Centre, John
Radcliffe Hospital, Oxford, UK, 8Broad Institute of MIT and Harvard, Cambridge, MA, USA, 9Division of
Hematology/Oncology, Children’s Hospital, Harvard Medical School, Boston, MA, USA, 10Department of Electrical
Engineering and Computer Science and Center for Computational Biology, University of California, Berkeley,
Berkeley, CA, USA, 11Ragon Institute of Massachusetts General Hospital, MIT and Harvard, Cambridge, MA, USA
and 12Chan Zuckerberg Biohub Investigator
Received March 20, 2017; Revised June 16, 2017; Editorial Decision June 27, 2017; Accepted July 12, 2017
ABSTRACT
The T cell compartment must contain diversity in
both T cell receptor (TCR) repertoire and cell state to
provide effective immunity against pathogens. How-
ever, it remains unclear how differences in the TCR
contribute to heterogeneity in T cell state. Single cell
RNA-sequencing (scRNA-seq) can allow simultane-
ous measurement of TCR sequence and global tran-
scriptional profile from single cells. However, current
methods for TCR inference from scRNA-seq are lim-
ited in their sensitivity and require long sequencing
reads, thus increasing the cost and decreasing the
number of cells that can be feasibly analyzed. Here
we present TRAPeS, a publicly available tool that can
efficiently extract TCR sequence information from
short-read scRNA-seq libraries. We apply it to inves-
tigate heterogeneity in the CD8+ T cell response in
humans and mice, and show that it is accurate and
more sensitive than existing approaches. Coupling
TRAPeS with transcriptome analysis of CD8+ T cells
specific for a single epitope from Yellow Fever Virus
(YFV), we show that the recently described ‘naive-
like’ memory population have significantly longer
CDR3 regions and greater divergence from germline
sequence than do effector-memory phenotype cells.
This suggests that TCR usage is associated with the
differentiation state of the CD8+ T cell response to
YFV.
INTRODUCTION
The population of antigen-specific CD8+ T cells formed in
response to infection or vaccination is highly heterogeneous
in terms of function and phenotype (1,2). Efforts to de-
convolve this cellular heterogeneity have used flow cytome-
try, mass spectrometry, and more recently, single-cell RNA-
sequencing (3). These approaches have identified a reliable
set of phenotypic markers that can classify antigen-specific
T cells into a large number of subsets, and distinguish them
from antigen-naive T cells. However, recent work also sug-
gests that some antigen-experienced CD8+ T cells can have
a naive-like phenotype, meaning that despite their poten-
tial to effectively respond to an antigen, they show tran-
scriptomic and surface marker similarities to antigen-naı¨ve
T cells (4–6). The cellular heterogeneity in the T cell com-
partment is thought to arise from different exposure to dif-
ferentiation cues such as antigen dose, duration of contact,
and cytokines. How the T cell receptor (TCR) sequence ex-
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pressed by each T cell contributes to that cellular hetero-
geneity is not fully understood.
The T cell receptor is a heterodimer of two chains––alpha
and beta, each consisting of three types of genomic
segments––variable (V), joining (J) and constant (C) (the
beta chain includes an additional short diversity (D) seg-
ment; Methods) (7). The V and J segments are selected out
of a pool of several dozen loci encoded in the germline
genome, through a recombination process. The diversity of
the TCR repertoire (estimated at∼107 in humans (7)) is fur-
ther enhanced by random insertions and deletions into the
complementarity determining region 3 (CDR3)––the junc-
tion between theV and J segments, which largely determines
the ability of the cell to recognize specific antigens. How-
ever despite this diversity, some T cell responses can include
TCRs that are identical between individuals - known as
‘public’ clonotypes, while other T cell responses use TCRs
that are unique to each individual (‘private’ clonotypes).
Previous studies have shown that these public clonotypes
tend to appear at a higher frequency and have a shorter
CDR3 region, possibly as a result of a more efficient recom-
bination process (7–10).
Unlike analysis of the cell state, the clonal diversity of
the TCR repertoire has to date been studied mostly in ag-
gregated samples from pools of T cells rather than individ-
ual cells (7,11,12). This approach has two significant limi-
tations: (i) since each chain of the TCR (alpha, beta) is a
separate transcript, it cannot determine which chains are
co-expressed in the same cell, leading to a partial view of the
TCR identity; (ii) the sequence of the TCR and the global
transcriptional state of the cell that expresses it cannot be
simultaneously determined. Previous studies have profiled
TCR use in single cells, but these studies were limited in the
number of transcripts that were quantified (11,13).
Single cell RNA-seq can generate full-length sequence in-
formation for many transcripts in individual cells includ-
ing the alpha and beta chains of the TCR. However, stan-
dard methods to map sequence fragments to the genome
(14) cannot be directly used for reconstructing and esti-
mating the abundance of TCRs because of the highly vari-
able nature of the CDR3 regions. One approach to address
this challenge is to rely on scRNA-seq with long sequenc-
ing reads (>100 bp), which can cover the entire CDR3 re-
gion along with the flanking V and J sub-segments (15).
The underlying TCR (along with the junctional diversifica-
tion events) can then be reconstructed using methods simi-
lar to TCR-seq population repertoire analysis (7,16). How-
ever, sequencing with long reads is costly and time consum-
ing, thus a method to successfully reconstruct TCRs from
shorter, paired-end reads is desirable. Another approach
(15,17,18) relies on previous methods for de-novo transcrip-
tome or genome assembly to reconstruct the CDR3 region
(19,20). In general, de-novo assemblers were designed with
a very large input data set and long reads in mind, and use
the concept of de-bruijn graphs to achieve high efficiency.
Indeed the TCR reconstruction methods that use this ap-
proach have mainly been tested on long RNA-seq libraries
(except scTCRseq which was also tested on simulated short
reads (17)). However, more accurate yet possibly more com-
putationally intensive algorithms are feasible and may be
more appropriate for the smaller target of reconstructing
only the TCR.
To address this, we have developed ‘TCR Reconstruc-
tion Algorithm for Paired-End Single cell’ (TRAPeS), a
software capable of accurately reconstructing TCRs from
paired-end sequencing libraries of single cells, even at short
(25 bp) read length. Unlike the previous methods, TRAPeS
does not reduce the input sequences into k-mers, but rather
works on the original reads - leading to increased sensitivity.
We benchmarked TRAPeS on a diverse set of viral stimula-
tions, and then demonstrate how simultaneous analysis of
TCR properties and global expression profiling in individ-
ual cells helps relate specific TCR properties such as CDR3
length to heterogeneity of T cell state among CD8+ T cells
that respond to YFV. TRAPeS is publicly available, and can
be readily used to investigate the relationship between the
TCR repertoire and cellular phenotype.
MATERIALS AND METHODS
TRAPeS
The TRAPeS algorithm has four main steps, each applied
separately to the alpha and beta chains:
1. Identifying putative pairs of V and J segments. In order
to recognize the V and J segments of the TCR, TRAPeS
takes as input the alignment of the RNA-seq reads to the
genome. TRAPeS searches for a paired-end read where
one mate maps to a V segment while the other mate is
mapped to a J segment, and takes those V–J pairs as pu-
tative candidates for the CDR3 reconstruction. In a case
where there are no such pairings, TRAPeS takes all pos-
sible V-J combinations of V and J segments that have
V–C and J–C pairing (i.e. reads where one mate maps
to V or J and the other mate maps to the C segments).
We note that reads are not successfully aligned to D seg-
ments of the beta chain due to their short length. Thus,
for the beta chain, reconstruction of the CDR3 includes
reconstruction of the D segment sequence. In addition,
TRAPeS allows the user to specify the maximum num-
ber of reconstructions per chain. If the number of pos-
sible V–J pairs exceeds this number, TRAPeS ranks the
pairs based on the number of reads initially mapped to
them, and only attempts to reconstruct the top pairs.
2. Collecting putative CDR3-originating reads. TRAPeS
finds the putative CDR3- originating reads by taking all
the unmapped reads whose mates map to the V/J/C seg-
ments. In addition, since the first step of the CDR3 re-
construction includes alignment to the genomic V/J se-
quences (see below), TRAPeS also collects the reads that
map to the V and J segments.
3. Reconstructing the CDR3. Using an iterative dynamic
programming algorithm, TRAPeS extends the V and J
regions. TRAPeS takes only the bases at the ends of
the V and J segments closest to the CDR3 (3′ of the V
segment and 5′ of the J segment). The number of ini-
tial bases is a parameter that can be tuned, set by de-
fault to min(length(V), length(J)). If the specified length
is longer than the J segment, TRAPeS concatenates the
J sequence to the beginning of the C sequence and use
this extended segment as the initial J segment. In each
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iteration, TRAPeS aligns all the reads to the V and
J segments separately with the Needleman–Wunsch al-
gorithm, using the following scoring scheme: +1 for a
match, –1 for a mismatch, –20 for gap opening and –
4 for gap extension. In addition, we don’t penalize for
having the read ‘flank’ the V and J toward their 3′ and
5′, respectively.
Next, TRAPeS takes all the reads that aligned to the
V and J segments above a certain score threshold, and
build the ‘extended’ V and J sequences based on the
reads. For each position, we take the base that appears
in most reads as the chosen sequence for this position.
This way, we extend the V and J regions in each iteration
and also correct for mutations or SNPs in the known ge-
nomic V and J segments. TRAPeS repeats this step until
the extended V and extended J overlap, or until TRAPeS
reaches a number of predefined iterations. If no over-
lap is found, TRAPeS also offers an optional ‘one-sided’
mode, where it will attempt to determine the productiv-
ity (see below) of only the extended V segment. For this
work, we used a threshold score of 21 for the alignment
of the reads. However, in some cases a lower threshold
was required, thus if no sequence was reconstructed we
run TRAPeS with a scoring threshold of 15.
4. Separating similar TCRs and determining chain produc-
tivity. Since some V and J segments have similar se-
quence, reads can be mapped to several segments, cre-
ating few similar putative V–J pairs. In addition, two al-
pha or beta chains can be created within a single cell.
TRAPeS takes all possible pairing and attempts to re-
construct the CDR3 region for all pairs. After recon-
struction, full-length TCR sequences are created by ex-
tending the reconstructed region with the known refer-
ence sequences. Then, TRAPeS runs RSEM (14) on all
reconstructed TCRs and the set of reads used as input
(and their mates) in order to rank the TCRs based on
the relative abundance. Next, TRAPeS determines if the
TCR is productive: V and J segments are in the same
reading frame and the CDR3 does not contain a stop
codon. TRAPeS outputs a filewith a summary of all pos-
sible reconstructions (see SupplementaryTable S1 for ex-
ample) for all cells, as well as separate files for each cell
with the full-length TCR sequences. For this paper we
used the productive chain with the highest expression as
the TCR sequence for each cell.
TRAPeS is implemented in python. To increase perfor-
mance, the CDR3 reconstruction using the dynamic pro-
gramming algorithm is implemented in C++, and uses the
seqan package (21). TRAPeS is freely available and can
be downloaded in the following link: https://github.com/
YosefLab/TRAPeS
TRAPeS can be easily extended to work with single-
end data. The reconstruction algorithm only requires the
paired-end information for the recognition of V/J segments
and CDR3-originating reads, which can be easily done in
single-end reads by searching for partial alignment of the
read edges to the V/J segments. This feature will be avail-
able in the next TRAPeS version.
Single cell sorting
Mouse LCMV experiments. Female C57BL/6 mice (The
Jackson Laboratory), aged 7 weeks, were infected with
2 × 105 plaque forming units (PFU) LCMV Armstrong
intraperitoneally i.p. or 4 × 106 PFU LCMV Clone 13
i.v. LCMV viruses were a generous gift from Dr. E John
Wherry (University of Pennsylvania, Perelman School of
Medicine). Peripheral blood was obtained from the mice at
day 7 post infection (p.i.) and lymphocytes were enriched
using LSM density centrifugation. Cells were prestained
with a near-IR fixable live/dead marker (Life Technologies,
cat# L34976) and an APC- conjugated dextramer reagent
for gp33 (Immudex, cat# A2160-APC) according to man-
ufacturer recommendations. The cells were then stained
with the following antibodies: FITC 2B4 (BioLegend, cat#
133504), PerCP-Cy5.5 CD44 (BioLegend, cat# 103032),
PE KLRG1 (BioLegend, cat# 138408), PE-Cy7 PD1 (Bi-
oLegend, cat# 135215), BV421 CD127 (BioLegend, cat#
135024), BV510 CD8A (BioLegend, cat# 100752).
Human CMV experiments (Donor 1). Blood samples
were obtained from a donor with detectable NLV-specific
CD8+ T cell response. Lymphocytes were enriched via
Ficoll gradient and prestained with a near-IR fixable
live/dead marker (Life Technologies, cat# L34976) and
an APC-conjugated dextramer reagent (Immudex, cat#
WB2132-APC). The cells were then stained with the fol-
lowing antibodies: FITC CD8A (BioLegend, cat# 300906),
PerCP-Cy5.5 CCR7 (BioLegend, cat# 353220), PE CD3
(BioLegend, cat# 317308), BV605 CD45RA (BioLegend,
cat# 304133).
Human YFV experiment (Donor 2). A healthy volunteer
was vaccinated with a single dose (0.5 ml containing at least
105 PFU) of 17D live-attenuated yellow fever vaccine strain
administered subcutaneously. Seroconversion after vacci-
nation was confirmed by assaying the neutralizing antibody
titers for YF-17D (data not shown). A whole blood sam-
ple was obtained 9 months post-vaccination and lympho-
cytes were enriched from whole blood via Ficoll gradient
centrifugation and a CD8 negative selection magnetic bead
kit (Miltenyi Biotec). Cells were prestained with a live/dead
marker (Life Technologies, cat# L34976) and an APC-
labeled tetramer reagent (NS4B 214–222 LLWNGPMAV,
kindly provided by Dr Rafi Ahmed). The cells were then
stained with the following antibodies: FITC CD8A (BioLe-
gend, cat# 300906), PE CXCR3 (BioLegend, cat# 353705),
PE-Cy7 CCR7 (BioLegend, cat# 353226), BV421 IL2Rb
(BioLegend, cat# 339009), BV510 CD3 (BioLegend, cat#
317332), BV605 CD95 (BioLegend, cat# 305627), BV780
CD45RA (BioLegend, cat# 304140).
Human hepatitis C experiment (Donor 3). Patient 355 (59-
year old Male, infected with genotype 1a HCV, baseline vi-
ral load 467 000 IU/ml) received a prime vaccination of
ChAd3-NSmut (2.5 × 1010 viral particles) and an MVA-
NSmut (2 × 108 plaque forming units) boost vaccination 8
weeks later. PBMCwere collected 14 weeks post-boost vac-
cination for assessment of single cell gene expression (22).
PBMCwere thawed and prestained with a live/deadmarker
(Life Technologies, cat# L34976) and a PE-conjugated
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pentamer reagent (PE-labeled HCV NS31406–1415 (KL-
SALGINAV; HLA-A*0201)). The cells were then stained
with the following antibodies: FITC 2B4 (BioLegend, cat#
329505), PerCP-eFluor 710 LAG3 (eBioscience, cat# 46–
2239), PE-Cy7 CCR7 (BioLegend, cat# 329919), APC
CD39 (BioLegend, cat# 328209), BV421 PD1 (BioLe-
gend, cat# 329919), BV510 CD3 (BioLegend, cat# 317332),
BV605 CD8A (BioLegend, cat# 301040), BV780 CD45RA
(BioLegend, cat# 304140).
The relevant institutional review boards approved all hu-
man subject protocols, and all subjects provided written
consent before enrollment.
Single cell sorts. All single cell sorts were performed on a
BD Aria II with a 70um nozzle. Cells were sorted into 5 l
of Qiagen TCLBuffer plus 1% beta-mercaptoethanol (v/v).
Immediately following sorting, plates were sealed, vortexed
on high for 30 s, and spun at 400 g for 1 min prior to flash
freezing on dry ice. Samples were stored at –80◦C until li-
brary preparation.
RNA sequencing
Single cell lysates were converted to cDNA following cap-
ture with Agencourt RNA Clean beads using the Smart-
Seq2 protocol as previously described (23). The cDNA
was amplified using 22–24 PCR enrichment cycles prior to
quantification and dual-index barcoding with the Illumina
Nextera XT kit. The libraries were enriched with 12 cycles
of PCR, then combined in equal volumes prior to final bead
cleanup and sequencing. All libraries were sequenced on an
Illumina HiSeq 2500 or NextSeq by either single-end 150
bp reads or short paired-end reads using the following read
lengths: mouse samples––30 bp, human donor 1––26 bp for
read 1 and 25 bp for read 2, human donor 2––30bp, hu-
man donor 3––26 bp. Donor 1 and donor 2 were sequenced
using two batches, where every batch had cells from all of
the donor’s population (i.e. donor 1 batch 1 had both naive
and CMV-specific cells, same for batch 2. Donor 2 batch
1 had YFV-specific, naive and effector memory cells, same
for batch 2). Donor 3′s entire sample was sequenced on a
single batch, and the LCMV samples from both mice were
combined and sequenced on a single batch (Supplementary
Table S2).
Preprocessing and Normalization of scRNA-seq data
Low quality bases were trimmed with trimmomatic
(24) using the following parameters: LEADING:15,
TRAILING:15, SLIDINGWINDOW:4:15, MINLEN:16.
Trimmed reads were then aligned to the genome (hg38 or
mm10 for human or mouse samples, respectively) with
TopHat2 (25) for TCR reconstruction, and aligned to
the transcriptome with RSEM (14) for transcriptome
quantification.
For transcriptome analysis of the human CMV and YFV
donors (donors 1 and 2), low quality cells were filtered out
prior to normalization. Cells were filtered out if their read
depth was less than 1 million pairs or if the cell expressed
less than 20% of all expressed transcript, where a transcript
was considered expressed if it had a transcripts per million
(TPM) value of >10 in at least 10% of cells, leaving 353 out
of 378 cells for further analysis.
Normalization of TPM values was done with our
newly developed normalization framework SCONE (https:
//niryosef.wordpress.com/tools/scone/). SCONE considers
a large number of unsupervised normalization pipelines (i.e.
without using any prior biological information about sam-
ples’ origin), applying different ways to scale the data (e.g.
full quantile, upper quantile) and perform factor analysis
to eliminate unwanted variation. SCONE then uses a num-
ber of quality metrics to choose the best normalization,
which reduces technical variation and maintain prior bio-
logical knowledge. In our study, the chosen normalization
first scaled each sample with the DEseq (26) scaling factor
to account for differences in sequencing depth. Then, we ran
RUVg (27) with k= 1. In order to run RUVg, a list of genes
that are constant across conditions should be provided. To
find constant genes across the specific conditions that were
tested in this paper, we also sequenced bulk populations of
naive CD8+ T cells from donor 1 and CMV-specific effec-
tor memory CD8+ T cells, as well as populations of 50 cells
of naive CD8+ T cells from donor 2 and YFV-specific ef-
fector memory CD8+ T cells. We ran DESeq2 (28) on those
samples and defined the set of constant genes as the genes
that showed no change (FDR-adjusted P-value > 0.98 and
absolute log fold change < 0.2) across all pairwise com-
parisons (naive vs. all effector memory cells, naive versus
CMV-specific effector memory, naive vs. YFV-specific ef-
fector memory and CMV-specific effector memory versus
YFV-specific effector memory), resulting in a total of 373
genes.
Dimensionality reduction with PCA on samples from
each donor after normalization revealed that the normal-
ization process maintain biological information, while re-
ducing the correlation between the data and technical vari-
ables such as batch, number of expressed genes in each cell,
and the values of the first PC of the quality matrix (where
the quality matrix includes for each cell technical informa-
tion as previously described (29) (Supplementary Figure
S10)).
Reconstructing TCR sequence from long reads
Detection of CDR3 sequence using long (150 bp) reads was
performed similar to Venturi et al. (7). In short, reads were
aligned against the set of known V and J segment using
blastn (30). Reads with V and J segments aligning to their
edges were selected, extracting the CDR3 sequence in each
read. In case where more than one productive CDR3 se-
quence was discovered in a cell, the sequence with the high-
est number of supporting reads was selected.
Reconstructing TCR sequence from short paired-end reads
using Trinity
Trinity (20) was run on each cell with the following pa-
rameters: –max memory 10G, –min contig length 50. In
addition, using the –KMER SIZE parameter Trinity was
run with four different k-mer sizes––13, 15, 17 and 19. For
each k-mer size we ran Trinity twice: once in single-end
mode, using the set of reads used by TRAPeS for CDR3
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reconstruction, and once in paired-end mode, taking all the
mapped and unmapped reads along with their pairs. Then,
for each k-mer we combined the final Trinity output from
both runs (paired-end and single-end) for each cell. To de-
termine whether or not a transcript is productive and to an-
notate the CDR3 sequence, all possible reconstructed tran-
scripts were run through IMGT/HighV-QUEST (31,32).
We considered each productive chain output by IMGT as
a successful reconstruction.
Comparing TRAPeS to TraCeR
TraCeR was run using default parameters. To compare
TRAPeS to TraCeR on the benchmark data used by
TraCeR (15), raw single cell RNA-seq data was down-
loaded as fastq files from ArrayExpress (accession number
E-MTAB-3857).While the original data consisted of 100 bp
paired-end reads, we converted it to that equivalent of short-
read sequences by trimming each fragment to leave only the
outer 25 or 30 bp of each read. We also ran TRAPeS on the
original 100 bp paired-end data with the following param-
eters: -score 80 -bases 150 -top 15 -byExp -oneSide
Comparing TRAPeS to scTCRseq and VDJPuzzle
VDJPuzzle was run using the default parameters. For
scTCRseq, since running the software with the default pa-
rameters resulted in no alignments for human TRBV seg-
ments, we ran the software using the parameters -e 1e-7 -c 2.
In addition, since scTCRseq does not summarize the data,
we collected the fasta sequences of scTCRseq final results
(*.gapfilled.final.vdj.fa files) and ran them through IMGT
to annotate the junction sequence in each cell, taking only
productive CDR3 with a complete reconstruction (no miss-
ing amino acids) as successful reconstructions. To compare
TRAPeS and scTCRseq on the benchmark data used by
scTCRseq (33), raw single cell RNA-seq data was down-
loaded as fastq files from ArrayExpress (accession number
E-MTAB-2512) and trimmed from 75 bp paired-end into 25
or 30 bp paired-end. We also ran TRAPeS on the original
75 bp paired-end data with the following parameters: -score
65 -bases 150 -top 10 -bases 100
Gini coefficient calculation:
For each population, cells were considered from the same
clone if they had identical CDR3 sequences of both alpha
and beta chains. Cells with only one reconstructed chain
were excluded from this analysis. The number of cells for
each clone was counted and the Gini coefficient was cal-
culated by using the Gini command in R from the ‘ineq’
package.
Inference of cell clusters, visualization and differential ex-
pression analysis
For cluster inference in the YFV + CMV human data, we
defined an expressionmatrix consisting of normalized TPM
values of 353 cells by 10827 transcripts (expressed at a level
of ≥5 TPM in at least 1% of cells; Supplementary Table
S11). We applied the SC3 software (34) for clustering the
cells in this matrix using default parameters.
To visualize the data, we first used the jackStraw package
(35) to reduce the dimensionality of the data and retain only
principal components (PC) that are statistically significant
(P-value < 10−4) in terms of the respective percent of ex-
plained variance. This analysis retained the first three PCs.
We then applied t-SNE (36) with default parameters and
2000 iterations to these significant PCs, further reducing the
data for visualization in two dimensions.
We used the DESeq2 package (28) to identify genes that
are differentially expressed (DE) between the different clus-
ters. In this application, each cluster was compared to the
other two clusters, looking for genes that are differentially
expressed. Genes were called as differentially expressed us-
ing an FDR-adjusted P-value cutoff of 0.05. The heatmap
in Figure 3B was populated with log2(TPM) values for
genes identified as uniquely up- or down- regulated in each
of three major phenotypic groups. We also see similar re-
sults of DE genes using the scRNA-seq analysis package
Seurat (37,38). Enrichment of DE genes with respect to im-
munological pathways was determined using a Fisher exact
test (FDR-adjusted P-value < 10−3) quantifying the signif-
icance of overlap between differential genes and signatures
from the ImmuneSigDB database (39).
Gene enrichment by signature analysis
We used FastProject (40) together with large collection of
transcriptional signatures from ImmuneSigDB (39) to char-
acterize the phenotype of our single cells. In short, each
transcriptional signature is comprised of genes that are ei-
ther over-expressed or under-expressed between two cell
states of interest (e.g. using published bulk RNA-seq data
from naive versus memory cells). For each single cell, the
signature score is computed as:
RS ( j ) =
∑
signs (i ) · X′i j · wi j/
∑
i∈S
wi j
where s is the signature, j is the cell, signs (i ) = −1 for
genes under-expressed in this signature and +1 for over-
expressed genes, X′i j is the standardized (Z-normalized
across all cells) log expression level of gene i in cell j , andwi j
is the estimated false-negative weight for gene i in cell j . To
identify transcriptional signatures that are associated with
an scRNA-seq data set of interest, FastProject looks for
consistency between signatures and low-dimensional pro-
jections of the data. To this end, FastProject first computes
a wide range of 2D projections (e.g. PCA, ICA, spectral em-
bedding, tSNE), each capturing (possibly different) key axes
of variation in the data. For each transcriptional signature
and each projection it then computes a consistency score,
which reflects the extent to which cells that have a similar
signature score reside close to each other in the projection
(thus extending our previous work (30) and facilitating the
analysis of non-linear projections). The significance of the
consistency score is evaluated by random shuffling.
To include only relevant signatures, we analyzed only sig-
natures with a significant consistency score (FDR-adjusted
P-value < 0.05) in at least one projection. In addition, only
signatures that include ‘CD8’ in their name were used for
further analysis, leaving a total of 95 signatures for the
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YFV + CMV human data and 154 signatures for the YFV-
specific analysis.
Characterization of TCR properties of YFV-specific cells
TCR expression. To compute the expression of each re-
constructed TCR, we added the reconstructed sequences
to the transcriptome and ran RSEM on the complete ex-
tended transcriptome, using the original sequencing results
(the complete fastq files) as input. This was performed for
each cell separately, i.e. for each cell only its TCR sequences
were added to the transcriptome. In cases where a cell had
more than one reconstructed alpha or beta chain (by hav-
ing two productive chains or having one productive and one
unproductive chain) they were both added to the transcrip-
tome.
Germline score. Classification of each base in the CDR3
as germline (originating from the V, D, J regions) or added
nucleotide was done by running the reconstructed TCR se-
quences thorough IMGT/V-Quest (41,42). The germline
score was calculated by dividing the number of nucleotides
encoded byV,D, J segments by the length of theCDR3 (16).
Comparing transcriptomic signatures with TCR length.
Identification of gene signatures associated with TCR
length was done with the PARIS algorithm (43), a mod-
ule in GenePattern (44). PARIS describes the association
between each signature score and TCR length by estimat-
ing their differential mutual information. For each signa-
ture, the mutual information is computed between the TCR
length and the signature, and then normalized using the
joint entropy. This score is rescaled with the mean of the
score of the TCR length against itself and the score of the
signature against itself, resulting in a rescaled normalized
mutual information (RNMI) matching score. The signifi-
cance of the score is evaluated by a permutation test (per-
formed on the TCR length) and then FDR correction.
Hydrophobicity. The mean hydrophobicity of each CDR3
was computed using the Kyte-Doolittle (45) numeric hy-
drophobicity scale. In order to account for CDR3 length,
we also computed mean hydrophobicity for each CDR3 us-
ing a sliding window (of both size 3 and 5), taking the mean
across all windows. However, the sliding window also didn’t
result in significant differences between YFV-specific naive-
like and YFV-specific effector memory-like cells (K–S test
P-value > 0.1, data not shown).
Normalized tetramer binding intensity. Normalized
tetramer binding intensity was defined based on flow cy-
tometry data acquired at the time of sorting. The tetramer
binding was measured with the APC-labeled tetramer
reagent. To correct for baseline expression of CD3, we
divided the APC-labeled tetramer measurement by the
expression of CD3 surface molecules.
RESULTS
TRAPeS reconstructs TCR sequences using short (25–30 bp)
scRNA-seq
TRAPeS starts by recognizing putative pairs of V and J seg-
ments that flank the CDR3 region, using genome alignment
(46) (Figure 1, top; see Materials and Methods for a com-
plete description of the algorithm). It then identifies the set
of unaligned reads thatmay have originated from theCDR3
region, taking the unmapped mates of reads aligned to the
putative V-J segments or to the constant (C) segment (Fig-
ure 1, middle). Next, it uses an iterative dynamic program-
ming scheme to piece together the putative CDR3 reads,
gradually extending the CDR3 reconstruction on both ends
(V and J) until convergence (Figure 1, bottom). Finally, af-
ter the TCR chain has been reconstructed, TRAPeS deter-
mines whether it is productive (i.e., has an in-frame CDR3
without a stop codon) and determines its exact CDR3 se-
quence, based on the criteria established by the interna-
tional ImMunoGeneTics information system (IMGT) (47).
For each cell, TRAPeS outputs a set of reconstructed TCR
transcripts (fromboth chains), alongwith their complete se-
quence, an indication of whether or not they are productive,
and the number of reads mapped to them. In some cases
multiple reconstructions can be generated for the same cell.
This may happen when more than one chain is produced in
the cell (a phenomenon that have been previously reported
(15,17,18)), or when sequence similarity between some V or
J segments results in several possible V-J pairs with an iden-
tical CDR3 reconstruction. In such cases, we report all V-J
pairs, while ranking the putative TCR transcripts in accor-
dance to their estimated expression levels (Supplementary
Table S1). The average running time of TRAPeS on a Hu-
man single cell library with an average twomillion reads per
cell is less than two minutes per cell on a standard machine
(Supplementary Figure S1).
TRAPeS is accurate and more sensitive than previous meth-
ods using short reads and comparable to previous methods us-
ing long reads
We applied and tested TRAPeS to scRNA-seq data from
a range of CD8+ T cell responses (Methods, Figure 2A).
These data sets were selected to include bothmouse and hu-
man CD8+ T cells as well as those expected to have a range
of TCR complexities (Supplementary Figure S2). In mice,
we used the lymphocytic choriomeningitis virus (LCMV)
infection model, and profiled CD8+ T cells responding to
either acute or chronic infection (using the Armstrong and
Clone 13 strains of LCMV, respectively). In healthy human
subjects we profiled naive CD8+ T cells, effector memory
CD8+ T cells, and antigen-specific CD8+ T cells elicited by
CMV infection; vaccination with the live attenuated yellow
fever virus infection (YFV-17D) (48); or by vaccinationwith
adenoviral and modified vaccinia Ankara vectors encoding
HCV proteins (6,22). We sorted up to 128 single CD8+ T
cells from each dataset to a total of 565 cells, and generated
scRNA-seq libraries with short (25–30 bp) paired-end reads
as previously described (23,49) and observed good quality
metrics using previously used measures (29) (Supplemen-
tary Table S2, Materials and Methods). To test TRAPeS,
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Figure 1. TRAPeS––an algorithm for TCR reconstruction in single cell RNA-seq Illustration of the TRAPeS algorithm. First, the V and J segment are
identified by searching for paired reads with one read mapping to the V segment and its mate mapping to the J segment. Then, a set of putative CDR3-
originating reads is identified as the set of unmapped reads whose mates map to the V, J and C segments. Finally, an iterative dynamic programming
algorithm is used to reconstruct the CDR3 region.
we applied cell quality filtering scheme similar to the crite-
ria used by others (15), removing samples with<2000 genes
or with>10% of reads mapping to mitochondrial genes, re-
sulting in a total of 513 high quality cells (Figure 2A). Im-
portantly, our results below remain consistent alsowhen cell
filtering is not applied (Supplementary Figure S3).
To evaluate the accuracy of TRAPeS, we compared its
output with that of directly sequencing the TCR sequence
using long reads (in which reconstruction is not required,
Materials and Methods). To that end, we sequenced li-
braries of epitope-specific cells forClone 13,Armstrong and
CMV, and naive T cells from the CMV donor with both
short (25–30 bp) paired-end and 150 bp single-end sequence
reads (Figure 2A). TCR sequences identified by TRAPeS
were almost perfectly consistent with those produced based
on the long read data (Methods; Figure 2B and C), indicat-
ing a high level of specificity.
We compared TRAPeS to previously published methods
for TCR reconstruction in single cells. First, we compared
TRAPeS to TraCeR (15)––a TCR reconstruction software
that is built upon Trinity (20), a de-novo transcriptome as-
sembly tool. We found that the sensitivity of TRAPeS was
markedly higher (Figure 2A–C). On average (across all data
sets), TRAPeS successfully reconstructed productive alpha
chains from 66% of the cells and productive beta chains
from 80% of the cells, using the short (25–30 bp) libraries.
In contrast, TraCeR resulted in no reconstruction for the 25
bp paired-end libraries, and was able, for the 30 bp libraries,
to reconstruct CDR3 regions in an average of 43% and 15%
of the cells for alpha and beta chains respectively.
Next, we considered two additional recently published
methods––VDJPuzzle (18) and scTCRseq (17), both based
on de-novo assembly algorithms (Trinity andGapFiller (19),
respectively). As above, we observe substantially higher sen-
sitivity with TRAPeS (Figure 2A–C, Materials and Meth-
ods). VDJPuzzle was also unable to reconstruct any produc-
tive chains in the 25 bp data and, for the 30 bp libraries, re-
constructed CDR3 regions in an average of 40% and 63% of
the cells for alpha and beta chains, respectively. scTCRseq,
which is build uponGapFiller (19), managed to successfully
reconstruct CDR3 regions in an average of 50% and 60%
of the cells for alpha and beta chains, respectively. While
scTCRseq achieves better results compared with Trinity-
based methods, TRAPeS clearly outperforms all methods
in terms of specificity and sensitivity (Figure 2A-C).
The low success rate of Trinity-based methods TraCeR
and VDJPuzzle is likely due to its requirement for seed k-
mer length (25nt) that is unsuitable for short reads. Thus,
we also directly ran Trinity on our set of CDR3-originating
reads, using a k-mer length of 13 (Materials and Methods).
This resulted in an increased sensitivity for the 30 bp li-
braries compared to TraCeR and VDJPuzzle, but did not
improve the reconstruction rates for 25 bp libraries (Figure
2A–C). Running Trinity with several other k-mer lengths
(15, 17 and 19) did not significantly change the results (Sup-
plementary Figure S4).
Notably, the average rate of successful reconstruction of
TRAPeS in our mouse libraries is 93.7% (with 30 bp reads),
which is higher than that achieved by TraCeR with the
mouse libraries used by Stubbington et al. (86.3% with 100
bp reads) (15). To further substantiate this result, we ap-
plied TRAPeS and TraCeR on a trimmed version of this
published data. We found that discarding 70–75% of the in-
formation (i.e. taking only 25 or 30 bp out of each 100 bp
read) substantially hurts the performance of TraCeR, while
TRAPeS is able to maintain rates of successful TCR recon-
structions that are similar to those achieved in the original
paper (15) (Supplementary Figure S5). Running TRAPeS
on the original long read data is also comparable to the suc-
cess rates obtained by TraCeR, demonstrating the ability of
TRAPeS to be applied on long reads as well (Supplemen-
tary Figure S5). In addition, running TRAPeS on short or
long reads is comparable to running scTCRseq using long
reads, as evident by running TRAPeS on the original and a
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Figure 2. Validation of TRAPeS and comparison to other methods (A) Success rates for reconstruction of productive CDR3 in various CD8+ T cell data
sets. Each line depicts the fraction of cells with a productive alpha or beta chain in a given data set with each one of the following methods––150 bp
sequencing (black line), short paired-end data reconstructed using TRAPeS (red), TraCeR (turquoise), scTCRseq (gray), VDJPuzzle (dark blue) or Trinity
(light blue). (B) Specificity of TRAPeS. Fraction of cells with identical CDR3 sequence between 150 bp data and the 25–30 bp data reconstructed either by
TRAPeS, TraCeR, scTCRseq, VDJPuzzle or Trinity. This was calculated as the fraction out of cells with a productive chain in both 150 and 25–30 bp data.
(C) Sensitivity of TRAPeS. Same as b, except the fraction of cells is calculated out of the total number of cells that had a successful reconstruction using
150 bp sequencing only. (D) Single cell RNA-sequencing captures a variety of clonal responses. Bars represent the Gini coefficient of each human CD8+
T cell data set. The Gini coefficient can range from zero (a complete heterogeneous population) to one (a complete homogenous population). Pie charts
represent the distribution of clones in each population, n represents the number of cells with a successful reconstruction of both alpha and beta chains.
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Figure 3. Transcriptome analysis reveals distinct subpopulation of YFV-specific cells exhibiting a naive-like profile. (A) t-SNE projection of 353 CMV-
specific, effector memory, YFV-specific, and Naı¨ve cells, using normalized transcripts per million (TPM) values of 10,827 transcripts. Ellipses indicate
three distinct spatial clusters. A discrete subset of YFV-specific cells cluster with Naive. (B) Genes differentially expressed between relevant phenotypic
groups. YFV-specific cells were classified as effector memory-like or naive-like using SC3, a non-spatial consensus clustering approach (Figure S7). (C)
t-SNE projections, each cell colored by relative signature score. Shown are two signatures from the ImmuneSigDB distinguishing CMV-specific from
YFV-specific cells, and two signatures distinguishing Naı¨ve or YFV-specific naive-like cells from effector memory, CMV-specific and YFV-specific effector
memory-like populations. (D) FACS protein expression of CCR7 and CD45RA surface molecules from index sort of Effector Memory, YFV-specific
effector memory-like, YFV-specific naive-like, and Naı¨ve cells.
trimmed version of the data used to benchmark scTCRseq
(17,33) (Supplementary Figure S6).
TRAPeS captures various clonality levels
We investigated the clonality of the TCR repertoire mea-
sured by TRAPeS among the human CD8+ T cells (Fig-
ure 2D, Supplementary Table S3), using the Gini Index, a
clonality measure (50) ranging from zero (i.e. no two cells
share the same TCR) to one (i.e. all cells are from the same
clone; Methods). As expected, the naı¨ve population had
a Gini index of zero, indicating that each naive CD8+ T
cell expressed a unique TCR. The CMV-specific CD8+ T
cell population had a high Gini index (with 83% of CMV-
specific CD8+ T cells with reconstructed alpha and beta
chains originated from a single clone), indicating a high de-
gree of oligoclonality as previously described (51, 52). In
contrast, CD8+ T cells elicited by YFV or HCV vaccines
showed much greater heterogeneity in TCR repertoire, con-
sistent with a more limited, rather than persistent, expo-
sure to antigen (6,53–56). This demonstrates the ability of
TRAPeS to capture cells from the same clone even with rel-
atively small number of antigen-specific cells, assuming a
clonal response.
Single-cell transcriptome analysis detects subpopulations of
YFV cells
In order to determine the relationship betweenTCRuse and
CD8+ T cell state, we focused on CD8+ T cells from two
healthy donors (YFV and CMV peptide-specific, as well as
naive and effector memory cells without sorting for peptide
specificity; Methods) to avoid introducing additional com-
plexity from chronic infection. To identify groups of cells
with similar expression profiles, we used SC3 (34), a robust
clustering method for sparse datasets, to identify subpopu-
lations of cells (Supplementary Figure S7, Supplementary
Table S4, Materials and Methods) which we then visual-
ized using t-SNE (36) (Figure 3A). We found three clus-
ters of cells: one that contained all CMV-specific cells (Fig-
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ure 3A, purple symbols); one that contained all effector
memory cells (blue symbols); and one that contained all
naive CD8+ T cells (green symbols). In contrast to these
discrete groupings, we observed that YFV-specific CD8+ T
cells were split between two clusters: one containing effec-
tor memory CD8+ T cells and one containing naive CD8+
T cells.
Differential gene expression analysis between cell clus-
ters revealed transcripts consistent with the known patterns
of gene expression in antigen-experienced or naive CD8+
T cells (Supplementary Tables S5–S7, Figure 3B, Materi-
als and Methods). CMV-specific CD8+ T cells expressed
effector molecules and transcription factors characteristic
of antigen experienced cells (e.g., Granzyme B, PRDM1),
which were not detected in naive cells. Naive CD8+ T
cells expressed canonical markers of the naive state (CCR7,
SATB1, LEF1) that were absent in CMV-specific and effec-
tor memory CD8+ T cells. The expression of these genes in
YFV-specific CD8+ T cells was consistent with the cluster
in which they were associated, with those in the naive clus-
ter expressing minimal Granzyme B or PRDM1, but show-
ing robust expression ofCCR7, SATB1, andLEF1 (Supple-
mentary Figure S8).
To identify broader patterns of transcriptional signa-
tures, we applied FastProject (40)––a software tool that en-
ables the expression of gene sets of interest to be quanti-
fied in transcriptional profiles of single cells (Materials and
Methods). We surveyed the enrichment of a collection of
gene sets, from the C7 (ImmuneSigDB) (39) collection of
MSigDB (57) corresponding to cell states and perturbations
of CD8+ T cells. We found significant up-regulation of mul-
tiple gene sets corresponding to naive CD8+ T cells (K–S
test FDR- adjustedP-value<0.01) in the naive cluster (clus-
ter 3) compared to the other two clusters. Consistent with
this, we found significantly greater up-regulation of effector
signatures in clusters 1 and 2 compared with the other clus-
ters (FDR-adjusted P- value< 0.01; Figure 3C and Supple-
mentary Table S8).
To confirm these patterns of transcript abundance at the
protein level, we compared flow cytometry data for a set
of surface markers acquired at the time of sorting (Meth-
ods) with transcript abundance in the same cell (Figure 3D).
Consistent with the gene expression profiles, we observed
that YFV-specific CD8+ T cells in the naive-like cluster
(open symbols) showed higher protein levels of CCR7 and
CD45RA than those in the effector memory cluster (purple
symbols). Thus, single-cell analysis shows that CD8+ T cells
specific for the same peptide epitope from YFV are hetero-
geneous and includes both effector-memory and naive-like
gene expression profiles, as has been reported previously for
cells analyzed at the bulk level (4,5,58).
Combined TCR-transcriptome analysis reveals longer CDR3
regions for naive-like YFV-specific cells
We reasoned that differences in TCR might contribute
to the heterogeneous differentiation of CD8+ T cells fol-
lowing YFV vaccination. To that end, we evaluated a
number of properties to characterize each reconstructed
TCR––CDR3 specific properties such as length, hydropho-
bicity and germline score as well as TCR expression. In ad-
dition, we measured the normalized tetramer staining in-
tensity per cell (Supplementary Table S9, Methods). We
then asked whether any of those properties differed between
naive-like and effector memory-like YFV-specific CD8+
T cells. Naive-like and effector memory-like YFV-specific
CD8+ T cells were indistinguishable (P-value>0.05, FDR-
adjusted P-value > 0.1) in terms of TCR transcript ex-
pression, hydrophobicity of the CDR3 region and normal-
ized tetramer staining intensity (Materials and Methods).
However, we found that the CDR3 sequence was signifi-
cantly longer in YFV-specific CD8+ T cells with a naive-like
state compared with those with an effector memory pro-
file for both alpha and beta chains (Figure 4A, K–S test
P-value 0.038 and 0.027 for alpha and beta chains respec-
tively, FDR-adjusted P-value = 0.084 for both alpha and
beta chains).
We next evaluated the germline score of CDR3 regions
in YFV-specific CD8+ T cells, a measure of the contri-
bution of germline nucleotides to the CDR3 region. The
germline score is defined as the ratio between the number of
nucleotides in the CDR3 that originate from the germline
(V, D, J segments) to the total number of nucleotides in
the CDR3 (16) (Materials and Methods). Consistent with
the differences in the CDR3 length, we found that naive-
like YFV-specific CD8+ T cells had a significantly lower
germline score in both alpha and beta chains than did effec-
tor memory-like cells (Figure 4B, K–S test P-value of 0.034
and 0.029 for alpha and beta chains respectively, FDR-
adjustedP-value 0.084 for both alpha and beta chains), sug-
gesting that generating the CDR3 region of these TCRs in-
volved a greater degree of nucleotide addition/subtraction.
To further characterize the relationship between CDR3
length and cellular state in YFV-specific CD8+ T cells, we
identified CD8+ transcriptional signatures (extracted from
ImmuneSigDB (39) and scored with FastProject (40), as
above) that correlated with CDR3 length across all YFV-
specific CD8+ T cells (Supplementary Table S10, Materials
and Methods). Of all signatures evaluated, we found that
only naive CD8+ T cell signatures showed a significant pos-
itive correlation with CDR3 length (FDR-adjusted P-value
< 0.1; Figures 4C andD). Previous work has suggested that
YFV-specific CD8+ T cells with a naive-like phenotype in-
clude those with a stem-cell memory (Tstem-memory) dif-
ferentiation state. We found that Tstem-memory signatures
were more enriched in naive-like YFV-specific CD8+ T cells
than in effector memory YFV-specific CD8+ T cells (Sup-
plementary Figure S9). However, the enrichment for these
signatures was equivalent between naive-like YFV-specific
and phenotypically naive CD8+ T cells, making it difficult
to discern whether these cells manifest a specific stem-cell-
like state. Our results, however, show that heterogeneity in
the differentiation state of CD8+ T cells responding to a sin-
gle epitope of YFV is strongly associated with the CDR3
length.
DISCUSSION
TRAPeS enables the analysis of TCR clonality in scRNA-
seq profiles using short sequence reads. Other methods of
direct TCR sequencing (7) or reconstruction (15,17,18) have
lower rate of successful TCR reconstruction or requires
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Figure 4. YFV-specific subpopulations display different TCR structure. (A) YFV-specific naive-like cells tend to have longer CDR3. Distribution of the
YFV-specific effector memory-like and naive-like CDR3 lengths in both alpha (left) and beta (right) chains. P-values were calculated with K–S test. (B)
Differences between naive-like and effector memory-like CDR3 lengths are due to added nucleotides. Distribution of the YFV-specific effector memory-
like and naive-like CDR3 germline scores, defined as the number of nucleotides in the CDR3 encoded by the V, D or J segments divided by the total
number of nucleotides in the CDR3, for both alpha (left) and beta (right) chains. P-values were calculated with K–S test. (C) Signature analysis reveals
significant correlation between CDR3 length and cell state. The plot depicts the rescaled normalized mutual information score between CDR3 length and
transcriptional signatures of CD8+ T cells from ImmuneSigDB. Signatures identified as statistically significant using a permutation test (FDR-adjusted
P-value < 0.1) are highlighted in red. (D) YFV-specific cells with long CDR3 tend to have a higher transcriptomic naive signature than cells with short
CDR3. Plot represents the score of each cell for a transcriptional signature of a naive versus effector CD8+ T cell state. A high signature score means that
a cell has higher expression of naive signature genes compared to effector signature genes.
long sequence reads, which substantially increase the per-
cell cost of single cell profiling. As single-cell RNA-seq tech-
nologies move towards massively parallel scale, long-read
sequencing is likely to become unfeasibly expensive, mak-
ing approaches such as TRAPeS critical for studies of TCR
use in single cells.
We applied TRAPeS to short-read sequencing data from
human CD8+ T cells and were able to discover a new as-
sociation between the differentiation state of CD8+ T cells
specific to a single YFV antigen and the CDR3 length of the
TCRs that they express. Long CDR3 lengths have been as-
sociated with private clonotypes, which in turn may reflect
low precursor frequency within the naive T cell pool (7–10).
We therefore speculate that within a population of naive T
cells capable of recognizing a specific antigen, those that ex-
ist at low frequency may enter the T cell response later than
more abundant precursors, resulting in an altered differen-
tiation state compared to those that existed at a higher pre-
cursor frequency. Alternatively, a greater degree of cross-
reactivity in T cells with short CDR3 regions may result in
more repeated TCR stimulation, leading to the difference in
T cell phenotype we observe. While in this case the pheno-
type could be validated with protein surface markers, this
is not true for many other phenotypes, highlighting the im-
portance of transcriptome analysis using scRNA-seq.
More generally, we anticipate that TRAPeS will facilitate
broad efforts to determine the relationship between T cell
state and TCR sequence in the immune response. TRAPeS
can be applied to further basic biological understanding of
the relationship between TCR avidity and T cell differenti-
ation. Being able to identify alpha and beta chains allows
cloning of TCRs into experimental systems to study their
binding properties, which will help determine how TCR
properties are related to TCR avidity and T cell biology.
This is highly relevant for studying vaccine responses and
for thymic development. Moreover, linking the CDR3 se-
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quence to T cell transcriptome can help identify biological
similarities in clonal populations of T cells. For instance, in
tumors where the identities of T cells responding to the tu-
mors are not known, identifying clonal expansion can be
used to infer tumor-specificities both for analyzing gene ex-
pression profiles and cloning both alpha and beta chains
of the same TCR for clinical use. Additionally, we recently
applied TRAPeS to study the clonality of CD4+ and HLA
class II-restricted CD8+ T cells in HIV-infected individuals
(59), demonstrating the wide use for a combined analysis of
transcriptome and TCR sequence at the same cell.
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